Researchers Find Arrays Miss Many CNVs; Recommend Combining Platforms, Algorithms to Improve Results
June 21, 2011
Researchers Find Arrays Miss Many CNVs; Recommend Combining Platforms, Algorithms to Improve Results
The team tested 11 different microarray platforms for the ability to detect CNVs and found that current methods of analysis only detect a portion of the CNVs in the genome in any given experiment.
Full-text access for premium subscribers only.
Existing premium subscribers login here.
New to GenomeWeb? Register here quickly.
New to GenomeWeb? Register here quickly.
Related Stories
- Amid Market Exits and Acquisitions, 2012 Saw Arrays Gain Ground in Prenatal, DTC Markets
January 2, 2013 / BioArray News - Cytogeneticists Say Platform Choice a Question of Personal Preference, Circumstance
August 21, 2012 / BioArray News - Signature Genomics to Adopt Agilent Platform in Light of Roche's Planned Departure from Array Market
July 31, 2012 / BioArray News - Affy, Agilent, Illumina Affirm Commitment to Array Market in Light of Roche's Planned Exit
June 19, 2012 / BioArray News - In Print: Last Month's Microarray Papers of Note
February 7, 2012 / BioArray News